Determining the potency of a biologic may require multiple methods. In addition, some methods may have complex responses that require critical fine-tuning to allow consistent collection of viable data. Complex methods can be validated and can provide consistent data if approached appropriately. Quality and laboratory professionals faced with validating a complex method for a novel product should attend this webinar to gain insights into navigating multifaceted methods. In addition attendees will receive recommendations on addressing orthogonal methods that support the validation of the selected potency method. Included is a discussion of selection of the method and the cell line. Also, correlating the method with the pharmaceutical activity of the product will be addressed. Finally, the timeline for method validation will be discussed as well as implementation of the validation per the protocol.
Course Objective:
• Correlation of method with activity
• Understanding requirements for complex, multi-stage methods
• Setting appropriate timelines
• Verification of critical materials
• Process monitoring
• Assessment of orthogonal methods
• Validation parameters
• Validation protocol
Course Outline:
• Identification of pathways involved in activity
• Selection of potency-indicating method(s)
• Identifying the cell line
• Selecting the assay platform
• Method development
• Creation of MCB and WCB
• Consideration of orthogonal methods
• FDA/EMEA/USP Guidelines
• Selection and documentation of reference standard
• Timeline for method validation
• Annual updates
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Compliance Professionals
• Validation Scientists
• Quality Assurance
• Quality Control
• Regulatory Affairs
• Laboratory Managers
• Assay Development Specialists working in biopharmaceuticals, pharmaceuticals, natural products/botanicals
QSR-Compliant Equipment Control & Validation of Processes in the Manufacturing Environment
Get Instant Access 90 Minutes View Program |
Methods for Detecting Mycoplasma Contamination In The Manufacture Of Pharmaceuticals and Biologics
Get Instant Access 90 Minutes View Program |
Bioavailability and Bioequivalence Studies submitted in NDAs and INDs
Get Instant Access 90 Minutes View Program |
Veterinary Feed Directive (VFD) Final Rule – What you need to know?
Get Instant Access 60 Minutes View Program |
Packaging and Labeling for Commercial and Clinical Products
Get Instant Access 90 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry